Cargando…

Modern surgical management of incidental gliomas

PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Pradhan, Anjali, Mozaffari, Khashayar, Ghodrati, Farinaz, Everson, Richard G., Yang, Isaac
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325816/
https://www.ncbi.nlm.nih.gov/pubmed/35704158
http://dx.doi.org/10.1007/s11060-022-04045-0
_version_ 1784757140557135872
author Pradhan, Anjali
Mozaffari, Khashayar
Ghodrati, Farinaz
Everson, Richard G.
Yang, Isaac
author_facet Pradhan, Anjali
Mozaffari, Khashayar
Ghodrati, Farinaz
Everson, Richard G.
Yang, Isaac
author_sort Pradhan, Anjali
collection PubMed
description PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incidentally diagnosed. These incidental low-grade gliomas (iLGG) maintain controversial treatment course despite scientific advancements. Here we highlight the recent advancements in classification, neuroimaging, and surgical management of these tumors. METHODS: A review of the literature was performed. The authors created five subtopics of focus: histological criteria, diagnostic imaging, surgical advancements, correlation of surgical resection and survival outcomes, and clinical implications. CONCLUSIONS: Alternating studies suggest that these tumors may experience higher mutational rates than their counterparts. Significant progress in management of gliomas, regardless of the grade, has been made through modern neurosurgical treatment modalities, diagnostic neuroimaging, and a better understanding of the genetic composition of these tumors. An optimal treatment approach for patients with newly diagnosed iLGG remains ill-defined despite multiple studies arguing in favor of safe maximal resection. Our review emphasizes the not so benign nature of incidental low grade glioma and further supports the need for future studies to evaluate survival outcomes following surgical resection.
format Online
Article
Text
id pubmed-9325816
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-93258162022-07-28 Modern surgical management of incidental gliomas Pradhan, Anjali Mozaffari, Khashayar Ghodrati, Farinaz Everson, Richard G. Yang, Isaac J Neurooncol Topic Review PURPOSE: Gliomas are the most common primary tumors of the central nervous system and are categorized by the World Health Organization into either low-grade (grades 1 and 2) or high-grade (grades 3 and 4) gliomas. A subset of patients with glioma may experience no tumor-related symptoms and be incidentally diagnosed. These incidental low-grade gliomas (iLGG) maintain controversial treatment course despite scientific advancements. Here we highlight the recent advancements in classification, neuroimaging, and surgical management of these tumors. METHODS: A review of the literature was performed. The authors created five subtopics of focus: histological criteria, diagnostic imaging, surgical advancements, correlation of surgical resection and survival outcomes, and clinical implications. CONCLUSIONS: Alternating studies suggest that these tumors may experience higher mutational rates than their counterparts. Significant progress in management of gliomas, regardless of the grade, has been made through modern neurosurgical treatment modalities, diagnostic neuroimaging, and a better understanding of the genetic composition of these tumors. An optimal treatment approach for patients with newly diagnosed iLGG remains ill-defined despite multiple studies arguing in favor of safe maximal resection. Our review emphasizes the not so benign nature of incidental low grade glioma and further supports the need for future studies to evaluate survival outcomes following surgical resection. Springer US 2022-06-15 2022 /pmc/articles/PMC9325816/ /pubmed/35704158 http://dx.doi.org/10.1007/s11060-022-04045-0 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Topic Review
Pradhan, Anjali
Mozaffari, Khashayar
Ghodrati, Farinaz
Everson, Richard G.
Yang, Isaac
Modern surgical management of incidental gliomas
title Modern surgical management of incidental gliomas
title_full Modern surgical management of incidental gliomas
title_fullStr Modern surgical management of incidental gliomas
title_full_unstemmed Modern surgical management of incidental gliomas
title_short Modern surgical management of incidental gliomas
title_sort modern surgical management of incidental gliomas
topic Topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325816/
https://www.ncbi.nlm.nih.gov/pubmed/35704158
http://dx.doi.org/10.1007/s11060-022-04045-0
work_keys_str_mv AT pradhananjali modernsurgicalmanagementofincidentalgliomas
AT mozaffarikhashayar modernsurgicalmanagementofincidentalgliomas
AT ghodratifarinaz modernsurgicalmanagementofincidentalgliomas
AT eversonrichardg modernsurgicalmanagementofincidentalgliomas
AT yangisaac modernsurgicalmanagementofincidentalgliomas